Bgm (BGM) Cash & Current Investments (2019 - 2025)
Bgm (BGM) posted quarterly Cash & Current Investments of $9.8 million for Q3 2025, down 15.96% year-over-year from $11.7 million in Q3 2024, and up 12.11% quarter-over-quarter from $8.8 million in Q1 2025.
Bgm (BGM) Cash & Current Investments (2019 - 2025) Analysis & Trends
Bgm (BGM) has reported Cash & Current Investments for 7 consecutive years, with $9.8 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Cash & Current Investments fell 15.96% year-over-year to $9.8 million; the TTM figure through Sep 2025 stood at $9.8 million (down 15.96% YoY), while the FY2025 annual figure was $9.8 million, down 15.96% from the prior year.
- Cash & Current Investments grew to $9.8 million in Q3 2025 per BGM's latest filing, from $8.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $20000.0 billion in Q1 2021 and bottomed at $446983.0 in Q1 2024.
- Historically, Cash & Current Investments has averaged $2578.4 billion across 5 years, with a median of $12.1 million in 2021.
- Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 100.0% — and 2025, when it surged 1859.66%.
- Bgm's Cash & Current Investments stood at $12.6 million in 2021, then advanced by 18.81% to $15.0 million in 2022, then plunged by 55.98% to $6.6 million in 2023, then surged by 77.23% to $11.7 million in 2024, then fell by 15.96% to $9.8 million in 2025.
- Business Quant data shows BGM's Cash & Current Investments at $9.8 million in Q3 2025, $8.8 million in Q1 2025, and $11.7 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Bgm | 30.61 Mn | 20.79 Mn | - | 9.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.82 Mn |
| Mar 31, 2025 | 8.76 Mn |
| Sep 30, 2024 | 11.69 Mn |
| Mar 31, 2024 | 446,983.00 |
| Sep 30, 2023 | 6.59 Mn |
| Mar 31, 2023 | 834.49 Bn |
| Sep 30, 2022 | 14.98 Mn |
| Mar 31, 2022 | 4,949.63 Bn |
| Sep 30, 2021 | 12.61 Mn |
| Mar 31, 2021 | 20,000.00 Bn |
| Sep 30, 2020 | 11.87 Mn |
| Sep 30, 2019 | 4.61 Mn |